Intra-Cellular Therapies, Inc. is developing innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders, thereby reducing the burden on patients ... read more
Intra-Cellular Therapies, Inc. is developing innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders, thereby reducing the burden on patients ... read more
Company InfoTeva is a global pharmaceutical leader and the world's largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our em ... read more
SciLucent, LLC, a Northern Virginia-based scientific consulting firm providing technical, regulatory, and product development services to developers, manufacturers, and marketers of pharmaceuticals an ... read more
OverviewAlnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitatin ... read more
Job DescriptionThe US Pharma Talent Management and Leadership Development Center of Excellence plays a critical role in our journey to reimagine talent and performance management, and, embed a talent- ... read more
OverviewAlnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitatin ... read more
Intra-Cellular Therapies, Inc. is developing innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders, thereby reducing the burden on patients ... read more
Intra-Cellular Therapies, Inc. is developing innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders, thereby reducing the burden on patients ... read more
Intra-Cellular Therapies, Inc. is developing innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders, thereby reducing the burden on patients ... read more